G
Genetic Archaeology
GENETIC ARCHAEOLOGY // PROFILE

TCF7L2

Transcription Factor 7 Like 2

CHR 10
10q25.2-q25.3

Overview

The TCF7L2 gene (Transcription Factor 7 Like 2) holds a unique position in metabolic genetics: across multi-ethnic genome-wide association studies, its common variant rs7903146 confers the single strongest common effect size for type 2 diabetes and gestational diabetes.

Unlike weight-centered genes such as FTO, TCF7L2 primarily alters how efficiently pancreatic beta cells respond to blood sugar rises via the gut incretin hormone GLP-1—a key relationship explored in our nutrigenomics diet guide.

📍 Position
10q25.2-q25.3 (Chromosome 10)
🏷️ Category
Metabolism & Blood Sugar
🧪 Function
Wnt Transcription Factor
📊 Influence
Beta-cell insulin release & T2D

Function of TCF7L2

As an effector of the Wnt signaling cascade, TCF7L2 regulates proglucagon gene transcription in intestinal L-cells and maintains GLP-1 receptor sensitivity on insulin-producing pancreatic islets.

Key Aspects:

🍭 Blunted Incretin Response

Carrying the rs7903146 T allele alters islet chromatin accessibility, reducing first-phase insulin release after refined carbohydrate meals.

🏃 Lifestyle Overrides Risk

Data from the landmark Diabetes Prevention Program (NEJM) proved that weight loss and 150+ min/week exercise nearly neutralized TCF7L2 TT risk.

💡 Preventive Proof: Even homozygous T/T carriers cut progression from prediabetes to diabetes by over 50% in the Diabetes Prevention Program through structured nutrition and walking.

🧬 Genetic Variants (SNPs)

Two intronic variants on chromosome 10q25 are consistently validated across global populations:

rs7903146
10:112998590
Reference

C
/
Risk Allele

T
IVS3C>T
Increases type 2 diabetes odds ~1.4-fold per copy (~1.9-fold for T/T), mediated via diminished beta-cell GLP-1 responsiveness.
T allele frequency:
~28% (Europe)
rs12255372
10:113049143
Reference

G
/
Variant

T
IVS4G>T
Closely linked marker associated with lower insulinogenic index and elevated postprandial blood glucose excursions.
T allele frequency:
~26% (Europe)

Practical Significance

✅ Strategies & Guidance

  • Low Glycemic Load Meals: Pair fibrous vegetables, legumes, and lean protein before starch to soften post-meal glucose spikes.
  • Post-Meal Movement: A 10–15 minute brisk walk after meals drives insulin-independent GLUT4 glucose uptake into muscle.
  • Routine Metabolic Labs: Monitor fasting glucose, HbA1c, and fasting insulin periodically, especially with family history.

⚠️ Clinical Notes & Risks

  • Postprandial Blood Sugar Spikes: Lean individuals carrying T/T can still develop impaired glucose tolerance.
  • Gestational Diabetes: Slightly elevated screening priority during pregnancy.
  • Refined Sugar Sensitivity: Liquid sugars and ultra-processed starches stress beta-cell capacity faster.
🩺 Medical Disclaimer: Genetic test results for TCF7L2 (Transcription Factor 7 Like 2) should always be interpreted alongside laboratory biomarkers, medications, and qualified medical or genetic counseling.

📚 Data Sources

  • OMIM: #602228 (Transcription Factor 7-Like 2)
  • dbSNP: rs7903146, rs12255372
  • NEJM / DPP Research Group: Florez et al. – TCF7L2 polymorphisms and progression to diabetes
  • Nature Genetics: Grant et al. – Variant of TCF7L2 confers risk of type 2 diabetes

Last Update: November 2026

Related Research Guides for TCF7L2

Related Genes in Metabolism